Adage Capital Partners Gp, L.L.C. Wave Life Sciences Ltd. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 9,622,104 shares of WVE stock, worth $102 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
9,622,104
Previous 9,703,351
0.84%
Holding current value
$102 Million
Previous $79.6 Million
49.59%
% of portfolio
0.22%
Previous 0.15%
Shares
12 transactions
Others Institutions Holding WVE
# of Institutions
192Shares Held
122MCall Options Held
430KPut Options Held
330K-
Ra Capital Management, L.P. Boston, MA18.2MShares$192 Million3.65% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$87.3 Million1.98% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$71.2 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.71MShares$71 Million0.81% of portfolio
-
M28 Capital Management LP Stamford, CT5.66MShares$59.9 Million56.95% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $918M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...